您当前的位置:
首页 >
文章列表页 >
Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells
更新时间:2024-04-03
    • Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 1, Pages: 95-102(2024)
    • DOI:10.13422/j.cnki.syfjx.20232025    

      CLC: R2-0;R22;R242;R285.5;R734.2
    • Published:05 January 2024

      Published Online:23 August 2023

      Received:26 May 2023

    扫 描 看 全 文

  • MU Qirui,LI He,LIU Yuetong,et al.Buzhong Yiqitang Regulates Apoptosis via Nrf2/ROS Pathway to Alleviate Cisplatin Resistance in A549/DDP Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(01):95-102. DOI: 10.13422/j.cnki.syfjx.20232025.

  •  
  •  

0

Views

24

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Treatment of Exercise-induced Fatigue with Buzhong Yiqitang Through Adipor1/AMPK/PGC-1α to Regualte Lipid Metabolism
Mechanism of Buzhong Yiqitang Intervening in Pyroptosis of AIT in NOD.H-2h4 Mice Based on NLRP3/Caspase-1/GSDMD Pathway
Effect of Buzhong Yiqitang on Th17/Treg Immune Imbalance and Notch1 Signaling Pathway in AIT Mice
Mechanism of PI3K/Akt/mTOR Signaling Pathway Against Non-small Cell Lung Cancer and Chinese Medicine Intervention: A Review

Related Author

PENG Juan
WEI Huani
JIANG Ting
LIU Wei
PAN Huashan
CHEN Daorui
WANG Zhimin
YANG Xiao

Related Institution

School of Physical Education and Health,Guangzhou University of Chinese Medicine
Lingnan Medical Research Center,Guangzhou University of Chinese Medicine
Guangdong Chaozhou Health Vocational College
The First Clinical College of Liaoning University of Traditional Chinese Medicine (TCM)
The Affiliated Hospital of Liaoning University of TCM
0